CDC- Cancer Survivorship Twitter Chat Tuesday, June 19th 2-3 pm EDT

Join Us! Cancer Survivorship Twitter Chat Tomorrow

Centers for Disease Control and Prevention (CDC)
 

CDC's Division of Cancer Prevention and Control (DCPC) will host a Twitter chat about cancer survivorship on Tuesday, June 19 from 2:00 to 3:00 pm EDT.

Subject matter experts Blythe Ryerson and Dr. Elizabeth Rohan will answer questions. Visit DCPC's Twitter account at twitter.com/CDC_Cancer. You can follow the chat using the hashtag #CDCCancerChat, and you can send questions for the chat using that hashtag now.


Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention

[Comment] Offline: Is CDC a science-based organisation? The Lancet

[Comment] Offline: Is CDC a science-based organisation?:

"When we published our first report describing discontent about the work of the Center for Global Health (CGH) at the US Centers for Disease Control and Prevention, CDC immediately contacted us to ask for an opportunity to reply. We agreed and await their response. Meanwhile, two further letters have arrived. They again signal severe concerns about the way in which CDC organises its global health work. Both correspondents are well informed about the details of the CDC's work in global health. Their allegations are serious." (subscription required $$$)

open access: Evaluation of Genomic Applications in Practice and Prevention (EGAPP) (breast, ovarian, Lynch Syndrome...)

Evaluation of Genomic Applications in Practice and Prevention (EGAPP): Implementation and Evaluation of a Model Approach

The EGAPP initiative was launched by the CDC Office of Public Health Genomics in the fall of 2004. The initiative's goal is to establish and evaluate a systematic, evidence-based process for assessing genetic tests and other applications of genomic technology in transition from research to clinical and public health practice. EGAPP also aims to integrate:

• existing recommendations on implementation of genetic tests from professional organizations and advisory committees.^1,2,3,4
• knowledge and experience gained from existing processes for evaluation and appraisal (e.g., US Preventive Services Task Force, CDC’s Task Force on Community Preventive Services), previous CDC initiatives (e.g., the ACCE process for assembling and analyzing data on genetic tests; http://www.cdc.gov/genomics/gtesting/ACCE/FBR/index.htm) 5, and the international health technology assessment experience.

............................................................................

Working Group: Topics

Completed Topics | Topics Under Review | Topics Identified

CDC Releases Infection Prevention Guide to Promote Safe Outpatient Care

CDC (U.S.) - Gynecologic Cancers - Inside Knowledge Campaign update Sept 2010

Inside Knowledge Campaign

CDC, in collaboration with the Department of Health and Human Services' Office on Women's Health, established the Inside Knowledge: Get the Facts About Gynecologic Cancer campaign to raise awareness of the five main types of gynecologic cancer: cervical, ovarian, uterine, vaginal, and vulvar. (A sixth type of gynecologic cancer is the very rare fallopian tube cancer.) When gynecologic cancers are found early, treatment is most effective. It is important for women to pay attention to their bodies and know what is normal for them so they can recognize the warning signs of gynecologic cancers.

Quality in Cancer Diagnosis (diagnostic pathology)

Summary

The quality of oncologic pathology testing currently is focused on the evaluation of testing steps involved in the ordering, procuring, processing, interpreting, reporting, and decision making based on pathology test results. Most errors in cancer diagnosis are related to several factors and not simply a pathologist's interpretation. Clinical practitioners may improve the safety of oncologic pathology testing services by facilitating communication between clinical services and pathology laboratories at all levels of testing.

CDC to Fund Molecular Genetic Test Pilot for Clinics, Labs | GenomeWeb